课题基金 / 基金详情

项目摘要

项目成果

Evan A. Scott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY-BIOMEDICAL RESOURCE CORE A major unmet challenge in kidney research is the inability of most traditional approaches and methods to harness the complexity of tissue function, structure, and cellular phenotypes. Innovations in nanotechnology provide powerful tools, reagents, and platforms that outperform traditional approaches in several areas of medicine, as clearly shown by stunning successes including mRNA vaccine development and oncology. Nevertheless, these resources are largely untapped by the kidney community and are unavailable in individual labs or institutions. Northwestern University (NU) is home to global leaders and pioneers in nanotechnology housed in the International Institute of Nanomedicine (IIN). During the tenure of the Northwestern O'Brien Kidney Center (NU-GoKIDNEY), we leveraged this unique scientific expertise at NU to establish and optimize services that deploy the power of nanotechnology in the service of kidney researchers in their efforts to develop more effective treatments for kidney diseases. The proposed Core builds on the momentum established through the Core B nanotherapeutic services offered by NU-GoKIDNEY, which includes 1) longstanding commitment to kidney research of nanomedicine leaders at NU who served as Core leaders and members of our Executive committee, 2) demonstrated interest in nanotechnology services by kidney investigators who requested nanotechnology services and submitted P&F proposals focused on nanomedicine solutions. These established services now form the basis of the following Specific Aims: Aim 1 will establish a Biomedical Resource Core to implement a service design for precision targeting of desired payloads to specific cells and sub-regions within the kidney; Aim 2 will establish SOPs and implement internal QA/QC and SOP protocols for all services offered; Aim 3 will ensure national access to resources by multiple mechanisms, that operate in collaboration with the consortium. In summary, the NU- Biomedical Resource Core will harness the power of nanotechnology to advance kidney health and provide an easily accessed portal to Core services for investigators throughout the US.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
  • 批准号:
    10626132
  • 项目类别:
  • 资助金额:
    $43.84万
  • 财政年份:
    2021
  • 负责人:
    Evan A. Scott
  • 依托单位:
Identification of the immunomodulatory mechanisms of nanocarrier-enhanced costimulation blockade in an allogeneic portal vein islet transplantation model
  • 批准号:
    10494100
  • 项目类别:
  • 资助金额:
    $18.98万
  • 财政年份:
    2021
  • 负责人:
    Evan A. Scott
  • 依托单位:
Identification of the immunomodulatory mechanisms of nanocarrier-enhanced costimulation blockade in an allogeneic portal vein islet transplantation model
  • 批准号:
    10303734
  • 项目类别:
  • 资助金额:
    $23.03万
  • 财政年份:
    2021
  • 负责人:
    Evan A. Scott
  • 依托单位:
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
  • 批准号:
    10457457
  • 项目类别:
  • 资助金额:
    $43.84万
  • 财政年份:
    2021
  • 负责人:
    Evan A. Scott
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: